v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2023   $ 654          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment   (2)          
Recognition of non-controlling interest upon capital investment   19          
Net income (loss)   (20)          
Ending balance at Mar. 31, 2024   651          
Beginning balance (in shares) at Dec. 31, 2023     2,071,144        
Beginning balance at Dec. 31, 2023 $ 12,028   $ 0 $ 42,264 $ (421) $ (30,594) $ 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,421        
Exercise of stock options 18     18      
Stock-based compensation 493     493      
Issuance of common stock for settlement of RSUs (in shares)     13,160        
Shares withheld related to net share settlement (in shares)     (478)        
Shares withheld related to net share settlement (36)     (36)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (8)       (8)    
Foreign currency translation adjustment (8)       (8)    
Net income (loss) (643)         (654) 11
Other 4     4      
Ending balance (in shares) at Mar. 31, 2024     2,086,247        
Ending balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Beginning balance at Dec. 31, 2023   654          
Ending balance at Sep. 30, 2024   946          
Beginning balance (in shares) at Dec. 31, 2023     2,071,144        
Beginning balance at Dec. 31, 2023 12,028   $ 0 42,264 (421) (30,594) 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 19            
Foreign currency translation adjustment (22)            
Ending balance (in shares) at Sep. 30, 2024     2,104,178        
Ending balance at Sep. 30, 2024 15,593   $ 0 42,825 (424) (27,621) 813
Beginning balance at Mar. 31, 2024   651          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment   (1)          
Net income (loss)   (19)          
Ending balance at Jun. 30, 2024   631          
Beginning balance (in shares) at Mar. 31, 2024     2,086,247        
Beginning balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,760        
Exercise of stock options 73     73      
Exercise of restricted stock units (in shares)     469        
Stock-based compensation 470     470      
Issuance of common stock for settlement of RSUs (in shares)     10,488        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     2,893        
Issuance of common stock under the Employee Stock Purchase Plan 103     103      
Shares withheld related to net share settlement (in shares)     (68)        
Shares withheld related to net share settlement (5)     (5)      
Repurchase of common stock (in shares)     (4,838)        
Repurchase of common stock (326)     (326)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (1)       (1)    
Foreign currency translation adjustment (41)       (41)    
Net income (loss) 1,027         1,015 12
Other 4     4   0 0
Ending balance (in shares) at Jun. 30, 2024     2,097,951        
Ending balance at Jun. 30, 2024 13,152   $ 0 43,062 (479) (30,233) 802
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   338          
Foreign currency translation adjustment   1          
Net income (loss)   (24)          
Ending balance at Sep. 30, 2024   946          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     1,650        
Exercise of stock options 25     25      
Stock-based compensation 452     452      
Issuance of common stock for settlement of RSUs (in shares)     9,924        
Shares withheld related to net share settlement (in shares)     (54)        
Shares withheld related to net share settlement (4)     (4)      
Repurchase of common stock (in shares)     (5,293)        
Repurchase of common stock (375)     (375)      
Re-measurement of non-controlling interests (338)     (338)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 28       28    
Foreign currency translation adjustment 27       27    
Net income (loss) 2,623         2,612 11
Other 3     3      
Ending balance (in shares) at Sep. 30, 2024     2,104,178        
Ending balance at Sep. 30, 2024 $ 15,593   $ 0 42,825 (424) (27,621) 813
Beginning balance at Dec. 31, 2024   93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   18          
Net income (loss)   (18)          
Ending balance at Mar. 31, 2025   93          
Beginning balance (in shares) at Dec. 31, 2024 2,107,953   2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 42,801 (517) (20,726) 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     657        
Exercise of stock options 8     8      
Stock-based compensation 448     448      
Issuance of common stock for settlement of RSUs (in shares)     10,293        
Shares withheld related to net share settlement (in shares)     (460)        
Shares withheld related to net share settlement (33)     (33)      
Repurchase of common stock (in shares)     (26,587)        
Repurchase of common stock (1,800)     (1,800)      
Re-measurement of non-controlling interests (18)     (18)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 1       1    
Foreign currency translation adjustment 31       31    
Net income (loss) 1,792         1,780 12
Ending balance (in shares) at Mar. 31, 2025     2,091,856        
Ending balance at Mar. 31, 2025 $ 22,812   $ 0 41,406 (485) (18,946) 837
Beginning balance at Dec. 31, 2024   93          
Ending balance at Sep. 30, 2025   158          
Beginning balance (in shares) at Dec. 31, 2024 2,107,953   2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 42,801 (517) (20,726) 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 1,399            
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax $ 4            
Foreign currency translation adjustment $ 83            
Ending balance (in shares) at Sep. 30, 2025 2,079,769   2,079,769        
Ending balance at Sep. 30, 2025 $ 28,997   $ 0 39,499 (430) (10,935) 863
Beginning balance at Mar. 31, 2025   93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   14          
Redemption of non-controlling interest   (39)          
Recognition of non-controlling interest upon acquisition   130          
Foreign currency translation adjustment   1          
Net income (loss)   (16)          
Ending balance at Jun. 30, 2025   183          
Beginning balance (in shares) at Mar. 31, 2025     2,091,856        
Beginning balance at Mar. 31, 2025 22,812   $ 0 41,406 (485) (18,946) 837
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     370        
Exercise of stock options 7     7      
Stock-based compensation 489     489      
Issuance of common stock for settlement of RSUs (in shares)     8,809        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     2,151        
Issuance of common stock under the Employee Stock Purchase Plan 119     119      
Shares withheld related to net share settlement (in shares)     (58)        
Shares withheld related to net share settlement (5)     (5)      
Repurchase of common stock (in shares)     (16,360)        
Repurchase of common stock (1,377)     (1,377)      
Re-measurement of non-controlling interests (14)     (14)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (2)       (2)    
Foreign currency translation adjustment 52       52    
Net income (loss) 1,366         1,354 12
Other 0            
Ending balance (in shares) at Jun. 30, 2025     2,086,768        
Ending balance at Jun. 30, 2025 23,447   $ 0 40,625 (435) (17,592) 849
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   64          
Redemption of non-controlling interest   (70)          
Reclassification of non-controlling interest 2 (2)         2
Net income (loss)   (17)          
Ending balance at Sep. 30, 2025   158          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     374        
Exercise of stock options 8     8      
Stock-based compensation 478     478      
Issuance of common stock for settlement of RSUs (in shares)     8,362        
Shares withheld related to net share settlement (in shares)     (73)        
Shares withheld related to net share settlement (7)     (7)      
Repurchase of common stock (in shares)     (15,662)        
Repurchase of common stock (1,471)     (1,471)      
Re-measurement of non-controlling interests (64)     (64)      
Reclassification of non-controlling interest 2 $ (2)         2
Purchase of capped calls (70)     (70)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 5       5    
Foreign currency translation adjustment 0            
Net income (loss) $ 6,669         6,657 12
Ending balance (in shares) at Sep. 30, 2025 2,079,769   2,079,769        
Ending balance at Sep. 30, 2025 $ 28,997   $ 0 $ 39,499 $ (430) $ (10,935) $ 863